Funds · 13F filer · New York, NY

Montanova Capital, LLC

$4.8B in 95 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+50.9%S&P 500 +20.9%
3y return+99.1%S&P 500 +68.5%
5y return+58.3%S&P 500 +74.5%
10y return+275.0%S&P 500 +256.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since June 30, 2016: $375 against $357 in the S&P 500.2

Montanova Capital, LLCS&P 500 (SPY)
$100$37520162026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
MANEVeradermics Inc$512.5M10.8%
ARQTArcutis Biotherapeutics Inc$326.1M6.9%
LEGNLegend Biotech Corp$204.2M4.3%−6.7%
PVLAPalvella Therapeutics Inc Ne$173.5M3.6%−1.6%
AVBPArrivent Biopharma Inc$156.9M3.3%+2.6%
BNTCBenitec Biopharma Inc$154.5M3.2%
Biohaven LtdCUSIP G1110E107$153.1M3.2%
AMDAdvanced Micro Devices Inc$149.4M3.1%
RCUSArcus Biosciences Inc$147.3M3.1%−5.1%
TSMTaiwan Semiconductor Manufac$145.5M3.1%+2.0%
NVDANvidia Corporation$144.2M3.0%+25.4%
EYPTEyepoint Inc$118.6M2.5%
SYYSysco Corp$118.0M2.5%+21.8%
GEGe Aerospace$116.0M2.4%
Immatics N.vCUSIP N44445109$113.4M2.4%
MGMMgm Resorts International$111.2M2.3%+7.7%
METAMeta Platforms Inc$99.0M2.1%+3.6%
CAPRCapricor Therapeutics Inc$98.6M2.1%+7.2%
KURAKura Oncology Inc$94.1M2.0%
GLUEMonte Rosa Therapeutics Inc$85.9M1.8%−16.0%
AVLNAvalyn Pharmaceuticals Inc$82.4M1.7%New
HDHome Depot Inc$79.7M1.7%+2.0%
HUTHut 8 Corp$77.3M1.6%New
COFCapital One Finl Corp$66.8M1.4%+10.2%
VMCVulcan Matls Co$63.4M1.3%+18.4%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
PVLAPalvella Therapeutics Inc NeDecember 31, 2024+1173.5%$173.5M
AMDAdvanced Micro Devices IncDecember 31, 2022+796.9%$149.4M
GLUEMonte Rosa Therapeutics IncJune 30, 2024+547.1%$85.9M
TSMTaiwan Semiconductor ManufacDecember 31, 2023+359.2%$145.5M
BNTCBenitec Biopharma IncSeptember 30, 2023+343.0%$154.5M
METAMeta Platforms IncSeptember 30, 2022+315.2%$99.0M
GEGe AerospaceJune 30, 2023+240.2%$116.0M
AMZNAmazon Com IncMarch 31, 2023+130.7%$48.8M
MANEVeradermics IncMarch 31, 2026+94.7%$512.5M
AVBPArrivent Biopharma IncMarch 31, 2024+94.5%$156.9M

Sold off last quarter

  • Apellis Pharmaceuticals IncCUSIP 03753U106 was $141.5M
  • Kalvista Pharmaceuticals IncCUSIP 483497103 was $96.0M
  • ERASErasca Inc was $55.6M
  • LTHLife Time Group Holdings Inc was $13.7M
  • WINGWingstop Inc was $9.2M
  • COHRCoherent Corp was $7.1M
  • Medtronic PLCCUSIP G5960L103 was $6.3M
  • Kezar Life Sciences IncCUSIP 49372L209 was $5.3M
  • MTDMettler Toledo International was $2.5M
  • TSLATesla Inc was $1.9M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+26.1%+14.8%
March 31, 2026−7.6%−4.6%
December 31, 2025+8.6%+2.4%
September 30, 2025+19.2%+7.8%
June 30, 2025+9.2%+10.5%
March 31, 2025−7.2%−4.6%
December 31, 2024−3.6%+2.1%
September 30, 2024+11.2%+5.4%
June 30, 2024−5.8%+4.0%
March 31, 2024+14.8%+10.0%
December 31, 2023+22.1%+11.2%
September 30, 2023−8.0%−3.6%
June 30, 2023+8.3%+8.3%
March 31, 2023+0.4%+7.0%
December 31, 2022+6.6%+7.1%
September 30, 2022−3.4%−5.3%
June 30, 2022−14.2%−16.5%
March 31, 2022−11.9%−4.9%
December 31, 2021−1.1%+10.7%
September 30, 2021−5.1%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1569064
  2. 2
    Filed August 14, 2026 · accession 0001172661-26-003727